Can asymmetric post‐translational modifications regulate the behavior of STAT3 homodimers?
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 2, p. 116, doi. 10.1096/fba.2019-00049
- By:
- Publication type:
- Article
Works matching IS 25739832 AND DT 2020 AND VI 2 AND IP 2
Results: 6
1
2
Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 2, p. 90, doi. 10.1096/fba.2019-00081
- By:
- Publication type:
- Article
3
Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 2, p. 77, doi. 10.1096/fba.2019-00070
- By:
- Publication type:
- Article
4
Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133<sup>+</sup> cells in clear cell renal carcinoma.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 2, p. 126, doi. 10.1096/fba.2019-00071
- By:
- Publication type:
- Article
5
Ultrastructure of primary pacemaking cells in rabbit sino‐atrial node cells indicates limited sarcoplasmic reticulum content.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 2, p. 106, doi. 10.1096/fba.2018-00079
- By:
- Publication type:
- Article
6
Issue Information.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 2, p. 73, doi. 10.1096/fba.1057
- Publication type:
- Article